Literature DB >> 10395200

A novel immunoglobulin superfamily junctional molecule expressed by antigen presenting cells, endothelial cells and platelets.

F Malergue1, F Galland, F Martin, P Mansuelle, M Aurrand-Lions, P Naquet.   

Abstract

The architecture of lymphoid microenvironments depends upon complex interactions between several stromal cell types. We describe in this report the cloning of a cDNA which encodes a novel membrane molecule containing two external Ig-like domains. It is expressed at the junction between endothelial cells including HEV. It is also expressed by platelets and MHC class II+ antigen presenting cells in thymic medulla and T-cell areas in peripheral lymphoid organs. These cells which lack in RelB-deficient mice include tissue-derived dendritic, epithelial cells and macrophages. Thus, this molecule might contribute to the organization of cell junctions in different microenvironments.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10395200     DOI: 10.1016/s0161-5890(98)00102-3

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  20 in total

1.  The cell polarity protein ASIP/PAR-3 directly associates with junctional adhesion molecule (JAM).

Authors:  K Ebnet; A Suzuki; Y Horikoshi; T Hirose; M K Meyer Zu Brickwedde; S Ohno; D Vestweber
Journal:  EMBO J       Date:  2001-07-16       Impact factor: 11.598

2.  PECAM-1/CD31 trans-homophilic binding at the intercellular junctions is independent of its cytoplasmic domain; evidence for heterophilic interaction with integrin alphavbeta3 in Cis.

Authors:  C W Wong; G Wiedle; C Ballestrem; B Wehrle-Haller; S Etteldorf; M Bruckner; B Engelhardt; R H Gisler; B A Imhof
Journal:  Mol Biol Cell       Date:  2000-09       Impact factor: 4.138

3.  Dual interaction of JAM-C with JAM-B and alpha(M)beta2 integrin: function in junctional complexes and leukocyte adhesion.

Authors:  Chrystelle Lamagna; Paolo Meda; Guillaume Mandicourt; James Brown; Robert J C Gilbert; E Yvonne Jones; Friedemann Kiefer; Pilar Ruga; Beat A Imhof; Michel Aurrand-Lions
Journal:  Mol Biol Cell       Date:  2005-08-10       Impact factor: 4.138

Review 4.  Dysregulation of JAM-A plays an important role in human tumor progression.

Authors:  Chen Zhao; Funian Lu; Hongxia Chen; Xianda Zhao; Jun Sun; Honglei Chen
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

5.  Effects of JAM-A deficiency or blocking antibodies on neutrophil migration and lung injury in a murine model of ALI.

Authors:  Sowmya P Lakshmi; Aravind T Reddy; Meghna U Naik; Ulhas P Naik; Raju C Reddy
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-08-17       Impact factor: 5.464

6.  Evidence for cross-reactivity of JAM-C antibodies: implications for cellular localization studies.

Authors:  Abigail Betanzos; Michael Schnoor; Eric A Severson; Tony W Liang; Charles A Parkos
Journal:  Biol Cell       Date:  2009-06-04       Impact factor: 4.458

7.  Expression of JAM-A in the human corneal endothelium and retinal pigment epithelium: localization and evidence for role in barrier function.

Authors:  Kenneth J Mandell; Lennart Berglin; Eric A Severson; Henry F Edelhauser; Charles A Parkos
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-09       Impact factor: 4.799

8.  Crystal structure of human junctional adhesion molecule 1: implications for reovirus binding.

Authors:  Andrea E Prota; Jacquelyn A Campbell; Pierre Schelling; J Craig Forrest; Melissa J Watson; Timothy R Peters; Michel Aurrand-Lions; Beat A Imhof; Terence S Dermody; Thilo Stehle
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-15       Impact factor: 11.205

9.  Identification of regions and residues in feline junctional adhesion molecule required for feline calicivirus binding and infection.

Authors:  Robert J Ossiboff; John S L Parker
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

Review 10.  JAM-related proteins in mucosal homeostasis and inflammation.

Authors:  Anny-Claude Luissint; Asma Nusrat; Charles A Parkos
Journal:  Semin Immunopathol       Date:  2014-03-26       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.